Skip to content
FrontierPicks

Watching

CCJ · Cameco

Conviction · Low · more likely to lag the S&P 500 over the next three months

Wrong if: a daily close above $83.84

Note written ·

Price against the kill line

15.6% clear of its kill line on the 13 November 2026 close.

How to read this

This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.

The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.

The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides

CCJCameco
$83.84
$70.73
15.6%well clear

Three months against the kill line

CCJ daily closes from 17 August 2026 to 13 November 2026, last $70.73, against its kill line: a daily close above $83.84. 17 August 2026: $98.5818 August 2026: $96.0319 August 2026: $97.9820 August 2026: $95.5921 August 2026: $102.5124 August 2026: $102.2725 August 2026: $106.9626 August 2026: $107.3627 August 2026: $106.3328 August 2026: $100.0131 August 2026: $98.761 September 2026: $96.262 September 2026: $96.383 September 2026: $100.624 September 2026: $100.748 September 2026: $101.979 September 2026: $100.4110 September 2026: $97.4211 September 2026: $96.6814 September 2026: $93.2615 September 2026: $91.2116 September 2026: $90.9017 September 2026: $92.8018 September 2026: $91.6221 September 2026: $93.2322 September 2026: $94.5923 September 2026: $90.8024 September 2026: $88.1225 September 2026: $88.0728 September 2026: $87.0429 September 2026: $86.8830 September 2026: $86.671 October 2026: $85.692 October 2026: $85.185 October 2026: $87.476 October 2026: $93.027 October 2026: $89.078 October 2026: $87.129 October 2026: $88.0612 October 2026: $86.1213 October 2026: $86.1514 October 2026: $81.4715 October 2026: $83.2316 October 2026: $81.5219 October 2026: $80.7020 October 2026: $80.5121 October 2026: $82.0222 October 2026: $78.9323 October 2026: $78.6026 October 2026: $79.0727 October 2026: $82.4128 October 2026: $83.8429 October 2026: $83.4930 October 2026: $76.912 November 2026: $73.383 November 2026: $72.564 November 2026: $71.685 November 2026: $68.336 November 2026: $71.309 November 2026: $75.3710 November 2026: $72.8711 November 2026: $74.3212 November 2026: $71.7813 November 2026: $70.73

Daily closes, to . Red: the kill line, a daily close above $83.84, on record since 11 November 2026. The shares are down 28.3% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.

Kill line

A daily close above $83.84, the highest close of the 20 sessions to 28 October 2026, which would show the shares leading the S&P 500; or Cameco's share of 2026 Westinghouse adjusted EBITDA above the US$430 million top of its outlook.

Research onlyNot in the portfolio.

Catalyst

The portfolio's record →

Key figures from the filings · Materials

Filed figures are not available: no quarterly report in US GAAP with the SEC (a foreign filer reports on Form 20-F or 40-F).

All filed numbers

What Cameco reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .

Short interest (FINRA, settled 15 October 2026, published 26 October 2026): the share of shares outstanding is not available, 2.4 days of average trading to cover, +15.4% since the previous report.

Insiders' open-market trades SEC Form 4, by trade date, to
Window Bought Sold
90 daysfrom $0 $0
12 monthsfrom $0 $0

The thesis

Cameco's shares are more likely to lag the S&P 500 over the next three months. Record long-term uranium prices have not yet reached its earnings, and a new US$1 billion share-sale program adds possible new stock supply. The full-year report expected in February 2027 settles whether contract repricing and the 49% Westinghouse stake turn into reported profit.

The rating is Low because the evidence since the third-quarter report on 30 October 2026 points one way. Cameco reported an adjusted net loss of C$2 million, or nil per share, against a $0.23 consensus in MarketBeat's preview. It raised its 2026 unit cost guidance and left its realized-price outlook unchanged, so uranium margins narrowed. Barclays cut its target to $89 from $95 on 2 November 2026.

The shares closed at $74.32 on 11 November 2026. They have bounced from the 52-week closing low of $68.33 on 5 November 2026 but remain below the $76.91 close of report day. The price reflects the miss: the shares are down 24.0% over three months and 45.0% below the 52-week high of $135.24 set intraday on 29 January 2026, while TradeTech's long-term uranium indicator stood at a record US$99.00 per pound on 31 October 2026.

Bullish and bearish views on Cameco Corporation

The bull case on Cameco Corporation (CCJ), in brief: term uranium price at a record. The bear case: third quarter missed on both lines.

Bull case

  • Term uranium price at a record. TradeTech's long-term price indicator was US$99.00 per pound on 31 October 2026, the highest since the series began in 1996, after four month-end readings at US$97.00, per Crux Investor on 3 November 2026. Cameco sells mostly under long-term contracts, so this price feeds its future contracts.
  • Realized prices kept rising. Cameco's third-quarter average realized uranium price was C$91.76 per pound against C$85.22 a year earlier, per Investing.com on 30 October 2026. The company held its 2026 realized-price outlook at C$91.00–96.00 per pound and revenue guidance at C$3,320–3,570 million.
  • A large contract book. Cameco has contracted average annual deliveries above 28 million pounds over the next five years, with commitments above that average in 2026–2028, per its third-quarter management's discussion and analysis (MD&A).
  • Westinghouse's quarter improved. Cameco's share of Westinghouse adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) was C$143 million in the third quarter of 2026, against C$124 million a year earlier. The full-year outlook for that share stayed at US$370–430 million.
  • Liquidity is ample. Cameco held C$860 million of cash against C$1.0 billion of debt on 30 September 2026, with an undrawn C$1.0 billion credit facility, per the third-quarter MD&A.

Bear case

  • Third quarter missed on both lines. Benzinga reported adjusted earnings of $0.00 per share on 30 October 2026, on sales of $619.0 million against a $767.67 million estimate. Revenue was C$619 million against C$615 million a year earlier, per the MD&A.
  • Costs are rising faster than prices. Cameco raised 2026 uranium unit cost of sales guidance to C$67.00–70.00 per pound from C$63.00–67.50 on 30 October 2026, per the third-quarter MD&A. The realized-price outlook did not move.
  • Production was trimmed. Cameco narrowed 2026 attributable production to 19.5–20.5 million pounds from 19.5–21.5 million on 30 October 2026. Third-quarter output was 3.5 million pounds against 4.4 million a year earlier, after an extended Key Lake mill shutdown.
  • New capacity to issue shares. Cameco signed a US$1 billion at-the-market equity distribution agreement on 5 November 2026, with agents' fees of up to 2% of gross proceeds, per TipRanks on 6 November 2026. It replaces a program dated 12 November 2024, and sales under it would add shares at market prices.
  • Analyst targets keep falling. Barclays cut its target to $89 from $95 on 2 November 2026 and kept an equal-weight rating, per Benzinga, two weeks after cutting it from a higher level on 19 October 2026. Truist cut its target to $125 on 22 October 2026 while keeping a buy rating.
  • Westinghouse is behind last year. Cameco's nine-month share of Westinghouse adjusted EBITDA was C$427 million, against C$569 million a year earlier, per the third-quarter release. The Westinghouse listing remains a confidential draft filing first disclosed on 30 July 2026, with no share count or price range.

Price setup

The shares closed at $74.32 on 11 November 2026, below the 50-day moving average of $85.80 and the 200-day moving average of $102.38. Both averages sit above the price, so the decline that began after the 29 January 2026 high has not reversed on either measure.

The closing low of $68.33 came on 5 November 2026, the day Cameco signed the share-sale agreement. Closes since then were $71.30 on 6 November 2026, $75.37 on 9 November 2026, $72.87 on 10 November 2026 and $74.32 on 11 November 2026. The report-day close of $76.91 on 30 October 2026 and the $83.49 close the day before mark the levels the shares lost on the results.

The main feature of the chart is the gap between commodity and equity. The long-term uranium price set a record on 31 October 2026 while the shares fell to a 52-week low. Benzinga described the same split on 13 October 2026: spot uranium holding firm while mining shares sank.

Catalysts ahead

  • 30 November 2026: TradeTech month-end long-term uranium price indicator. A reading at or above the record US$99.00/lb of 31 October 2026 would show contract pricing still rising, the input to Cameco's future realized prices.
  • No confirmed date: CNSC decision on the 20-year Port Hope conversion facility licence renewal, after the hearing held in the week of 2 November 2026. The current licence expires on 28 February 2027; renewal on normal terms removes a risk to Cameco's fuel services business. CNSC staff found Cameco operated safely.
  • ~February 2027 (est.): Cameco fourth-quarter and full-year 2026 results. Shows whether realized prices land inside C$91.00–96.00/lb, unit costs hold at or below C$70.00/lb, and Westinghouse reaches its US$370–430 million outlook.
  • No confirmed date: Public filing of Westinghouse's US registration statement. A public share count and price range would put a market value on Cameco's 49% stake; the draft has been confidential since its disclosure on 30 July 2026.

What would change the view

A daily close above $83.84, the highest close of the 20 sessions to 28 October 2026, which would show the shares leading the S&P 500; or Cameco's share of 2026 Westinghouse adjusted EBITDA above the US$430 million top of its outlook.

What it trades with

Cameco trades with uranium miners and nuclear-power equities. It has diverged from the uranium price since the third-quarter report, so the commodity has been a poor short-term guide to the shares. Westinghouse news, including AP1000 reactor orders and any public listing filing, moves the stock alongside other nuclear-build names. Cameco reports in Canadian dollars while its NYSE shares trade in US dollars, so exchange-rate moves affect both reported margins and the US share price.

The evidence, claim by claim (8)
  1. Third-quarter 2026 revenue was C$619 million against C$615 million a year earlier; net earnings were C$43 million (C$0.10 per share) and adjusted net loss was C$2 million (nil per share). Cameco Q3 2026 MD&A, Form 6-K · as of
  2. Benzinga reported Q3 adjusted EPS of $0.00 and sales of $619.0 million against a $767.67 million estimate; MarketBeat's pre-report consensus was $0.23 per share. Benzinga 30 October 2026; MarketBeat earnings preview 23 October 2026 · as of
  3. 2026 uranium unit cost of sales guidance was raised to C$67.00–70.00/lb from C$63.00–67.50/lb; realized-price outlook held at C$91.00–96.00/lb and revenue at C$3,320–3,570 million. Cameco Q3 2026 MD&A, Form 6-K · as of
  4. Cameco narrowed 2026 attributable production guidance to 19.5–20.5 million lb from 19.5–21.5 million lb; Q3 output was 3.5 million lb against 4.4 million lb a year earlier. Cameco Q3 2026 results release · as of
  5. Cameco's share of Westinghouse adjusted EBITDA was C$143 million in Q3 2026 (C$124 million a year earlier) and C$427 million for nine months (C$569 million); full-year outlook US$370–430 million unchanged. Cameco Q3 2026 results release and MD&A · as of
  6. TradeTech's long-term uranium price indicator was US$99.00/lb, the highest since the series began in 1996, after four month-end readings at US$97.00. Crux Investor, 3 November 2026, citing TradeTech · as of
  7. Cameco entered a US$1 billion at-the-market equity distribution agreement with Canadian and US agents, who may receive fees of up to 2% of gross proceeds; it replaces the agreement dated 12 November 2024. TipRanks, 6 November 2026; Cameco Form 6-K 5 November 2026 · as of
  8. Barclays kept an equal-weight rating on Cameco and lowered its price target to $89 from $95. Benzinga, 2 November 2026 · as of

Sources

Related · shared themes

Every buy and sale, with its reason, is published in the portfolio feed. Follow the portfolio feed → Follow @frontierpicks on X